# Mend

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mend

- Industry: Food
- Headquarters: New York, US
- Website: www.mend.me
- Total disclosed funding: $10M
- Latest round: Series A (Apr 24, 2023)
- Investors on record: 7

## About

Based in New York, US, and founded in 2014 by its president, Helene Rutledge, and CEO, Eziah, and co-founded by Whitney Stevens and Justin Kamine, MEND Nutrition Inc., doing business as Mend operates as a biotechnology company focused on nutritional science research. In July 2023, Siphox, Inc. raised USD 10 million in seed funding co-led by Khosla Ventures and Y Combinator, with participation from investors CEP America, LLC, Longevity Tech Fund, M2I2, Metaplanet Holdings, and Rsquared. As of 2023, the company has a client base including companies like Petterwood Orthpaedics, Geisinger, Premier, and many more.

MEND offers various research and novel targeted solutions by partnering with advisors, partners, and clients. The company’s product portfolio includes Upgraid™, product formulated using natural, organic ingredients used to promote healing and overall well-being. It caters for repairing bones and tissues to enhancing energy levels and supporting healthy muscles.

## Funding rounds

- Series A, Apr 24, 2023, $10M — iSelect Fund Management, Alumni Ventures Group, S2G Ventures, Touchdown Ventures, KEEN Growth Capital, Colorcon Ventures, GenHenn Capital

## Investors

- iSelect Fund Management (https://capitalatlas.ai/funds/iselect-fund-management) — Series A
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series A
- S2G Ventures (https://capitalatlas.ai/funds/s2g-ventures) — Series A
- Touchdown Ventures (https://capitalatlas.ai/funds/touchdown-ventures) — Series A
- KEEN Growth Capital (https://capitalatlas.ai/funds/keen-growth-capital) — Series A
- Colorcon Ventures (https://capitalatlas.ai/funds/colorcon-ventures) — Series A
- GenHenn Capital — Series A